Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by TYL, R. W.
Right arrow Articles by LOSCO, P. E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by TYL, R. W.
Right arrow Articles by LOSCO, P. E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1995 Oxford University Press

research-article

Assessment of the Developmental Toxicity of Ethylene Glycol Applied Cutaneously to CD-1 Mice1

R. W. TYL2, L. C. FISHER, M. F. KUBENA, M. A. VRBANIC and P. E. LOSCO

Bushy Run Research Center/Union Carbide Corporation, Export Pennsylvania 15632

Received August 16, 1993; accepted January 31, 1995

Ethylene glycol (EG; CAS No. 107-21-1) is teratogenic to mice by whole-body exposure to an aerosol at high concentrations, but results were confounded by possible exposure from ingestion after grooming and/or from percutaneous absorption. Therefore, CD-1 mice were exposed to EG on Gestational Days (GD) 6 through 15, 6 hr/day by occluded cutaneous application at 0, 12.5, 50, or 100% (undiluted) EG (0.1 ml/animal, equivalent to {small tilde}0, 404,1677, or 3549 mg/kg/day, respectively) or by gavage on GD 6 through 15 at 3000 mg/kg/day [10 ml/kg, positive control gavage group (PCGG)], 30 females/group. Dams were weighed and evaluated daily (including application site) for clinical signs and water consumption throughout gestation. On GD 18, maternal uterus, liver, and paired kidneys were weighed; kidneys of 0 and 100% and the PCGG were examined microscopically. Corpora lutea and implantation sites were recorded. Live fetuses were weighed, sexed, and examined for structural alterations. For cutaneously exposed dams, there was no treatment-related maternal toxicity, no differences in pre- or postimplantation loss or in fetal body weights/ litter, and no increased incidences of any fetal malformations. Two skeletal variations, increased at 100%, may represent effects of restraint stress and/or findings due to chance. In the PCGG, 8 females (26.7%) died, water consumption was increased, fetal body weights/litter were reduced, and fetal malformations and variations were increased. PCGG kidneys exhibited tubular nephrosis and tubular cell degeneration, with no oxalate crystals, documenting renal toxicity at this oral dose in mice. Minimal-grade renal tubular lesions observed in 3 mice (of 30) at 100% EG may represent treatment-related or incidental findings. Therefore, exposure of pregnant CD-1 mice to 0, 12.5, 50, or 100% EG during organo-genesis by occluded cutaneous application resulted in minimal or no observable maternal or developmental toxicity at 100% ({small tilde}3549 mg/kg/day), the NOEL.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.